





| Catalog No. | HV185016 |
|---|---|
| Description |
Romosozumab (HV185016) is a research-grade recombinant antibody targeting SOST. Produced in mammalian cells with native-like glycosylation.
Highlights
|
| Species reactivity | Human |
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Host species | Human |
| Isotype | IgG2-kappa |
| Expression system | Mammalian cells |
| Clonality | Monoclonal |
| Target | SOST, Sclerostin |
| Endotoxin level | Please contact the lab for this information. |
| Purity | >95% purity as determined by SDS-PAGE. |
| Purification | Protein A/G purified from cell culture supernatant. |
| Accession | Q9BQB4 |
| Form | Liquid |
| Storage buffer | 0.01M PBS pH 7.4 Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Alternate Names | 785A070802, AMG785, CDP-7851, romosozumab-aqqg, sclerostinAb, CAS: 909395-70-6 |
| Background | Sclerostin (SOST) is a ~24 kDa protein. Negative regulator of bone growth that acts through inhibition of Wnt signaling and bone formation. |
| Note | For research use only. Not suitable for clinical or therapeutic use. |

SEC-HPLC detection for Research Grade Romosozumab.

Detects Human SOST in indirect ELISAs.

SDS-PAGE for Research Grade Romosozumab.




Contact us for custom quotes, bulk requests and any other issues.
Mail: support@abinScience.com






+86-27-87433958
Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China
中文
English
한국어
日本語
Español
Français
Русский